20 results on '"Zarubica, Ana"'
Search Results
2. Neutralization of SARS-CoV-2 and Intranasal Protection of Mice with a nanoCLAMP Antibody Mimetic
3. INFRAFRONTIER quality principles in systemic phenotyping
4. Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
5. Abstract 4677: A preclinical platform of breast cancer PDX and derived cellular models as a tool for pharmacological screening and functional studies
6. Abstract 4678: Characterization of a PDX panel covering molecular diversity of non-small cell lung cancer to accelerate the development of precision therapy
7. Abstract 5184: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
8. Abstract 4630: Deep Immuno-profiling of syngeneic tumor mouse models for preclinical studies
9. Abstract 5190: Systematic immune-profiling of immune-deficient mouse models: A rational to select ideal host for tumor implantation
10. 1107 Anti-HVEM mAB therapy improves antitumoral immunity bothin vitroand in a novel mice model expressing human HVEM and BTLA molecules using HVEM expressing tumors
11. Meningeal macrophages protect against viral neuroinfection
12. Age-dependent meningeal macrophages protect against viral neuroinfection
13. Viral infection engenders bona fide and bystander subsets of lung-resident memory B cells through a permissive mechanism
14. Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
15. Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19
16. Viral infection engenders bona fide and bystander lung memory B cell subsets through permissive selection
17. Control of CDH1 /E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19.
18. Characterisation of 5 anti-viral therapeutics in preclinical COVID-19 mouse models
19. Secondary phenotyping analysis of 15 mouse models
20. Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.